New regulation means stricter requirements for medtech firms

On Wednesday, new regulations for medtech equipment came into force in the EU. The regulations increase patient safety while complicating matters for medtech companies that sell products on the European market. An industry association criticizes the lead-up.

Starting Wednesday, medtech companies will need to live up to a new set of requirements if they plan on selling their equipment on the EU market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs